Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alterity Therapeutics (ATHE) Operating Leases (2019 - 2025)

Alterity Therapeutics has reported Operating Leases over the past 1 years, most recently at $76018.8 for Q2 2019.

  • For Q2 2019, Operating Leases changed N/A year-over-year to $76018.8; the TTM value through Jun 2019 reached $76018.8, changed N/A, while the annual FY2019 figure was $76018.8, N/A changed from the prior year.
  • Operating Leases for Q2 2019 was $76018.8 at Alterity Therapeutics.
  • Over five years, Operating Leases peaked at $76018.8 in Q2 2019 and troughed at $76018.8 in Q2 2019.